Oral Oncology
Volume 37, Issue 6 , Pages 505-512 , September 2001

Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection

  • L Zhang

      Affiliations

    • Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC, Canada, V6T 1Z3
    • ,
  • C.F Poh

      Affiliations

    • Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC, Canada, V6T 1Z3
    • ,
  • W.L Lam

      Affiliations

    • BC Cancer Agency/Cancer Research Centre, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
    • ,
  • J.B Epstein

      Affiliations

    • Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC, Canada, V6T 1Z3
    • BC Cancer Agency/Cancer Research Centre, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
    • Vancouver General Hospital, 855 West 12th Avenue, Vancouver, BC, Canada, V5Z 1M9
    • School of Dentistry, University of Washington, Seattle, WA 98195, USA
    • ,
  • X Cheng

      Affiliations

    • Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC, Canada, V6T 1Z3
    • School of Kinesiology, Simon Fraser University, Burnaby, BC, Canada, V5A 1S6
    • ,
  • X Zhang

      Affiliations

    • School of Kinesiology, Simon Fraser University, Burnaby, BC, Canada, V5A 1S6
    • ,
  • R Priddy

      Affiliations

    • Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC, Canada, V6T 1Z3
    • ,
  • J Lovas

      Affiliations

    • Faculty of Dentistry, Dalhousie University, 5981 University Ave, Halifax, NS, Canada, B3H 3J5
    • ,
  • N.D Le

      Affiliations

    • BC Cancer Agency/Cancer Research Centre, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
    • ,
  • M.P Rosin

      Affiliations

    • BC Cancer Agency/Cancer Research Centre, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
    • School of Kinesiology, Simon Fraser University, Burnaby, BC, Canada, V5A 1S6
    • Corresponding Author InformationCorresponding author. Present address: British Columbia Cancer Agency, Cancer Control Research Unit, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6. Tel.: +1-604-291-4589; fax: +1-604-291-3040

Received 18 November 2000 ,Accepted 11 December 2000.

References 

  1. Scully C. Oral precancer: preventive and medical approaches to management. Oral Oncol, Eur J Cancer. 1995;31:16–26
  2. Tradati N, Grigolat R, Calabrese L, Costa L, Giugliano G, Morelli F, et al.  Oral leukoplakia: to treat or not?. Oral Oncol. 1997;33:317–321
  3. McCartan B. Malignant transformation of leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:348
  4. Allen CM. Malignant transformation of leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:348–349
  5. Lee JJ, Hong WK, Hittleman W, Mao L, Lotan R, Shin DM, et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000;6:1702–1710
  6. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:321–329
  7. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53:563–568
  8. Bosatra A, Bussani R, Silvestri F. From epithelial dysplasia to squamous carcinoma in the head and neck region: an epidemiological assessment. Acta Otolaryngol. 1997;527(Suppl.):47–48
  9. Lovas J. Oral precancer: patterns, complexities and clinical guidelines. JCDA. 1989;55:209–214
  10. Chiesa F, Boracchi P, Tradati N. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncol, Eur J Cancer. 1993;29B:23–28
  11. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piatadosi S, et al.  Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488–2492
  12. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A’Hern RP, Langdon JD. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res. 2000;60(14):3893–3898
  13. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus: a premalignant lesion?. Am J Pathol. 1997;8:323–327
  14. Zhang L, Cheng X, Li Y-H, Poh C, Zeng T, Priddy R, et al.  High frequency of allelic loss in dysplastic lichenoid lesions. Lab Invest. 2000;80:233–237
  15. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med. 1996;2:682–685
  16. Rosin MP, Cheng X, Poh CF, Lam WL, Huang Y, Lovas J, et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000;6(2):357–362
  17. Mao L. Can molecular assessment improve classification of head and neck premalignancy?. Clin Cancer Res. 2000;6:321–322
  18. WHO Collaborating Reference Centre for Oral Precancerous Lesions . Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. 1978;46:517–539
  19. Mashberg A, Meyer H. Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas. Cancer. 1976;37:2149–2157
  20. Moore C, Catlin D. Anatomic origins and locations of oral cancer. Am J Surg. 1967;114:510–513
  21. Schepman KP, van der Waal I. A proposal for a classification and staging system for oral leukoplakia: a preliminary study. Oral Oncol, Eur J Cancer. 1995;1B(6):396–398
  22. Westra WH, Sidransky D. Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. JNCI. 1998;90:1500–1501
  23. Partridge M, Emillion G, Pateromichelakis S, A’Hern R, Phillips E, Langdon J. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol. 1998;34:77–83
  24. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287:2017–2019
  25. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res. 2000;6(7):2718–2725
  26. Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, Fan Y, et al.  Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. JNCI. 1998;90:1541–1551
  27. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986;315:1501–1505
  28. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. New Engl J Med. 1995;332:429–435
  29. Einhorn J, Wershall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer. 1967;20(12):2189–2193

PII: S1368-8375(00)00140-8

Oral Oncology
Volume 37, Issue 6 , Pages 505-512 , September 2001

Article Tools

* Image Usage & Resolution